SILDENAFIL ZENTIVA 100 Milligram Film Coated Tablet Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sildenafil zentiva 100 milligram film coated tablet

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 100 milligram

SILDENAFIL ZENTIVA 50 Milligram Film Coated Tablet Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sildenafil zentiva 50 milligram film coated tablet

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 50 milligram

SILDENAFIL ZENTIVA 25 Milligram Film Coated Tablet Írsko - angličtina - HPRA (Health Products Regulatory Authority)

sildenafil zentiva 25 milligram film coated tablet

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 25 milligram

Solpadol 500 mg/30 mg Effervescent Tablets Írsko - angličtina - HPRA (Health Products Regulatory Authority)

solpadol 500 mg/30 mg effervescent tablets

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate - effervescent tablet - 500mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol

Suprecur 150 micrograms/ metered dose Nasal Spray, solution Írsko - angličtina - HPRA (Health Products Regulatory Authority)

suprecur 150 micrograms/ metered dose nasal spray, solution

sanofi-aventis ireland limited t/a sanofi - buserelin - nasal spray, solution - 150 microgram(s) - gonadotropin releasing hormone analogues; buserelin

SUPREFACT 100 Mcg/Dose Nasal Spray Solution Írsko - angličtina - HPRA (Health Products Regulatory Authority)

suprefact 100 mcg/dose nasal spray solution

sanofi-aventis ireland limited t/a sanofi - buserelin acetate - nasal spray solution - 100 mcg/dose - gonadotropin releasing hormone analogues

Suprefact 1 mg/ml Solution for Injection Írsko - angličtina - HPRA (Health Products Regulatory Authority)

suprefact 1 mg/ml solution for injection

sanofi-aventis ireland limited t/a sanofi - buserelin - solution for injection - 1 milligram(s)/millilitre - gonadotropin releasing hormone analogues; buserelin

Tarivid IV 2 mg/ml Solution for Infusion Írsko - angličtina - HPRA (Health Products Regulatory Authority)

tarivid iv 2 mg/ml solution for infusion

sanofi-aventis ireland limited t/a sanofi - ofloxacin - solution for infusion - 2 milligram(s)/millilitre - fluoroquinolones; ofloxacin

LIFSAR PULMOJET 50/500 Microgram Powder for Inhalation Írsko - angličtina - HPRA (Health Products Regulatory Authority)

lifsar pulmojet 50/500 microgram powder for inhalation

sanofi-aventis ireland limited t/a sanofi - salmeterol xinafoate, fluticasone propionate - powder for inhalation - 50/500 microgram - adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics - adrenergics, inhalants; adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics. - lifsar pulmojet is indicated for the symptomatic treatment of adults with chronic obstructive pulmonary disease (copd) with a fev1 < 60% predicted normal (pre-bronchodilator) and a history of repeated exacerbations and who have significant symptoms despite regular bronchodilator therapy.

Lysopadol 17.86 mg/ml oromucosal spray, solution Írsko - angličtina - HPRA (Health Products Regulatory Authority)

lysopadol 17.86 mg/ml oromucosal spray, solution

sanofi-aventis ireland limited t/a sanofi - ambroxol hydrochloride - oromucosal spray, solution - 17.86 milligram(s)/millilitre - anesthetics, local